Geldsp. z o.o.

Legal activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-08-28
Share capital
5,000.00 PLN
Registered address
ul. Gen. Felicjana Sławoja Składkowskiego 3/261, 02-497 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 91 days for 2021).

  • 202520/07/2026
  • 202416/07/2025
  • 202323/07/2024
  • 202215/07/2023
  • 202114/10/2022
  • 202014/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Legal activities1,507 / 2,543
Top 59%
Top 54%
Top 55%
Voivodeship · Mazowieckie84,522 / 142,033
Top 60%
Country · Poland304,067 / 495,860
Top 61%

Results vs industry

Revenue
This companyUSD 78.60kMedianUSD 130.87kAverageUSD 978.59k
Net profit
This companyUSD -24.66kMedianUSD 14.04kAverageUSD 205.25k
Operating costs
This companyUSD 103.27kMedianUSD 88.43kAverageUSD 709.27k
Assets
This companyUSD 50.00kMedianUSD 90.91kAverageUSD 661.38k

Authorized Representatives

Jerzy Romuald Rogalski – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Rafał Dominik Rogalskiage 50
46$1,242.5792%
Others
4$108.058%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-09-05.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

FAQ

Last updated: 2026-07-20